Status:
COMPLETED
Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Alkermes, Inc.
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare intensive and standard training for human insulin inhalation powder in patients with type 2 diabetes.
Eligibility Criteria
Inclusion
- Type 2 diabetes for at least 12 months
- Age 18 or older.
- Taking at least 1 oral antihyperglycemic medication.
- Have an HbA1C between 7.5 and 12.
- Be a nonsmoker
Exclusion
- Body Mass Index (BMI) greater than 40.
- Have frequent episodes of severe hypoglycemia.
- Have advanced autonomic neuropathy.
- Have history of asthma.
- Have chronic obstructive pulmonary disease (COPD).
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00099515
Start Date
November 1 2004
End Date
September 1 2005
Last Update
December 21 2007
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Clearwater, Florida, United States
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Buffalo, New York, United States
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
New Hyde Park, New York, United States
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Sante Fe, Rosario, Argentina